ACE2 and COVID-19: Triterpene glycoside, glycyrrhizin (7) (Figure 2) may reduce the severity of an infection with COVID-19 at the two stages of the COVID-19 induced disease process, (1) by blocking the number of entry points and (2) by providing an ACE2 independent anti-inflammatory mechanism.